Future work to define the circulating factors in HF patients, such as HMGB1, pro-inflammatory cytokines, reactive oxygen nitrogen stress, and metabolites, in relation to endothelial function and survival are warranted to support the current result. The gene discussed is HMGB1; the disease is hydrops fetalis.